NextCure Inc expected to post a loss of 66 cents a share - Earnings Preview

NextCure

30/10/2023 12:50

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show no
change in
quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for NextCure Inc is for
a
loss of 66 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for NextCure
Inc is
$6​, above​ its last closing price of $1.07. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.59       -0.59      -0.64     Missed  -8.5
 Mar. 31 2023  -0.62       -0.62      -0.58     Beat    6.5
 Dec. 31 2022  -0.65       -0.66      -0.62     Beat    5.5​
 Sep. 30 2022  -0.62       -0.63      -0.68     Missed  -8.7
 ​​Jun.        -0.72       -0.72      -0.65     Beat    9.7
 30 2022                                                
 Mar. 31 2022  -0.67       -0.67      -0.74     Missed  -10.7​
 Dec. 31 2021  -0.67       -0.67      -0.61     Beat    9.1
 Sep. 30 2021  -0.66       -0.67      -0.65     Beat    2.5
 This summary was machine generated October 30 at 12:50 GMT.  All
figures in US dollars  unless otherwise stated